<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02965105</url>
  </required_header>
  <id_info>
    <org_study_id>CP271</org_study_id>
    <nct_id>NCT02965105</nct_id>
  </id_info>
  <brief_title>Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers</brief_title>
  <official_title>Clinical Study Investigating Safety and Performance of a New Urinary Intermittent Catheters in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coloplast A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coloplast A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to test the performance and safety of a newly developed intermittent
      catheter
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>1 day</time_frame>
    <description>Pain experienced by the subjects at catheterisation is measure with the VAS scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Incontinence, Urinary</condition>
  <arm_group>
    <arm_group_label>First Coloplast Test Catheter; then Speedicath</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects allocated to this arm first test Coloplast Test Catheter and then after cross over test the comparator Speedicath Catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>First Speedicath; then Coloplast Test Catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects allocated to this arm first test Speedicath Catheter and then after cross over test Coloplast Test Catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coloplast Test Catheter</intervention_name>
    <description>This is a newly developed intermittent catheter</description>
    <arm_group_label>First Coloplast Test Catheter; then Speedicath</arm_group_label>
    <arm_group_label>First Speedicath; then Coloplast Test Catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Speedicath</intervention_name>
    <description>This is a marketed Catheter which is used as comparator</description>
    <arm_group_label>First Coloplast Test Catheter; then Speedicath</arm_group_label>
    <arm_group_label>First Speedicath; then Coloplast Test Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Have given written informed consent and signed letter of authority 2. Be at least
             18 years of age and have full legal capacity 3. Be a male 4. Willing to refrain from
             using analgetics up to 24 hours prior to catheterization visits 5. Have a negative
             urine multistix - erythrocytes (Microscopic haematuria) 6. Have a negative urine
             multistix:

               -  Leukocytes

               -  Nitrite Or if positive, subsequent negative for bacterial growth in urine culture

        Exclusion Criteria:

          1. Abnormalities, diseases or surgical procedures performed in the lower urinary tract

          2. Symptoms of urinary tract infections (at least one of the following: frequent
             urination, stinging or pain at urination)

          3. Participating in other clinical investigations related to urinary tracts system during
             this investigation (inclusion to termination) or have previously participated in this
             investigation

          4. Known hypersensitivity toward any of the test products -
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Bagi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD at the clinic for urology at Rigshospitalet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshopsitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>København Ø</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2016</study_first_submitted>
  <study_first_submitted_qc>November 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2016</study_first_posted>
  <last_update_submitted>February 28, 2017</last_update_submitted>
  <last_update_submitted_qc>February 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

